Since 2001, executive manager of Jenal & Partners Biosafety Consulting advising industry, academia and authorities on an international level on all issues related to biosafety and biosecurity: risk assessment of dual use potential of biological research, biosecurity assessment, risk assessment of contained use activities of all levels; risk assessment of nano-bio-materials; environmental risk assessment for gene and cell therapy and recombinant vaccine clinical trials and market authorisation applications; guidelines on safe use of cell cultures, plant pathogens, transport, waste treatment; biorisk management systems, crisis management, biorisk management audits, ISO140001 audits, biosafety and biosecurity training, safe procedure design, project management. Capacity building training in South East Asian (CBRN European action plan) and Africa regarding biosafety and biosecurity (Twinning by Sandia National Laboratories USA).